Spot Trading’s Tempest Therapeutics TPST Stock Holding History

Spot Trading’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1	Closed	-$28K	–	4077
2015 Q3	$28K	Buy	+1	New	+$67.3K	﹤0.01%	3433

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's TPST Position: Q4 2015 in Review

Spot Trading sold out of Tempest Therapeutics (TPST) in Q4 2015, closing a stake of 1 share — an estimated $28K sold.

Spot Trading first reported a position in TPST in Q3 2015 and held it in 1 quarter. The position peaked at $28K in Q3 2015. 78 funds tracked by Wall St. Rank hold TPST as of Q4 2015.

Spot Trading reported no remaining Tempest Therapeutics position as of Q4 2015 after selling out during the quarter.
Spot Trading sold 1 Tempest Therapeutics share in Q4 2015, an estimated $28K.
Spot Trading first reported a position in Tempest Therapeutics in Q3 2015 and held it in 1 quarter.
Spot Trading's Tempest Therapeutics position peaked at $28K in Q3 2015.
78 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.